Navigation Links
Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association

it."

SNS-032 is a potent, selective inhibitor of CDKs 2, 7 and 9 that inhibits both cell cycle progression and transcription of anti-apoptotic signals key to the survival of B-cell malignancies. SNS-032 is currently being studied in a Phase 1 dose-escalation safety trial in patients with B-cell malignancies, including chronic lymphocytic leukemia, mantle cell lymphoma and multiple myeloma. Sunesis plans to present preliminary data from this ongoing Phase 1 trial by year's end.

Data on SNS-595 and SNS-032 were presented at the 12th Congress of European Hematology, organized by The European Hematology Association (EHA) on Saturday, June 9, 2007 in two poster sessions:

    -- Abstract #0489: "Pharmacokinetic/Pharmacodynamic Correlation with

       Responses in a Phase 1 Study of Patients with Relapsed/Refractory Acute

       Leukemias Treated with SNS-595"

    -- Abstract #0742: "SNS-032 Exhibits Dose-Dependent Mechanism-Based

       Inhibition of CDK7 and CDK9 in Peripheral Blood Mononuclear Cells from

       Patients with Advanced Cancers Treated in an Ongoing Phase 1 Trial"

About Sunesis' Oncology Programs

Sunesis has built a rich portfolio of product candidates in oncology focused on novel pathways and targets, including inhibition of the cell-cycle and survival signaling. Sunesis is currently conducting Phase 2 clinical trials in lung and ovarian cancer and a Phase 1 clinical trial in acute leukemias for its lead compound, SNS-595. SNS-032, a selective inhibitor of cyclin-dependent kinases 2, 7 and 9, is being evaluated in Phase 1 clinical trials in B-cell malignancies and in advanced solid tumors. The company's Aurora kinase inhibitor, SNS-314, is expected to begin Phase 1 clinical trials in mid-2007. In addition, Sunesis is developing novel small molecule inhibitors of Raf kinase and other oncology kinases in collaboration with Biogen Idec.

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biop
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
2. Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
3. Sunesis Presents Data Supporting SNS-032s Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
4. Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research
5. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
(Date:7/7/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... offering of 32,000,000 units. Each unit consists of one share ... purchase one share of common stock at a purchase ... units in the offering would result in them beneficially ...
(Date:7/7/2015)... July 7, 2015 Oasmia ... of drugs within human and veterinary oncology, today ... in the United States , ... leading companion animal therapeutic.      (Logo: ... ) , Paccal Vet-CA1 was ...
Breaking Medicine Technology:Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... , , , ... service Contract Research Organization (CRO) founded in India, today announced the ... Application Suite (OLSAS) by going live with Oracle Siebel Clinical Trial ... , "We are excited to have the rollout of ...
... Aug. 5 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... a New Drug Submission (NDS) with the Therapeutic Products ... the antidepressant trazodone. , "We are pleased to file ... R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. ...
Cached Medicine Technology:SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 3
(Date:7/7/2015)... ... July 07, 2015 , ... Quadrino Law Group is pleased to ... Melville, New York 11747. The new facility is a state of the art ... , Richard Quadrino, the firm's CEO and founder, said, "We are pleased to service ...
(Date:7/7/2015)... ... July 07, 2015 , ... Safe Catch is setting revolutionary purity limits ... Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market and Wegmans are some ... technology to test every fish for mercury,” said Safe Catch co-founder Sean Wittenberg. “We ...
(Date:7/7/2015)... ... ... Parents and guardians of teenagers or young adults will be interested in reading ... drug and alcohol abuse located in Southwest Michigan. A recently released study by New ... in the “club drug” use among high school seniors. The blog post offers guidance ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... ... promotion on teeth whitening treatments. A professional teeth whitening is one of the fastest, ... appearance, as well as they can decrease smile satisfaction and confidence. With the right ...
(Date:7/7/2015)... and Wellesley, MA (PRWEB) , ... July 07, ... ... National Institute of Whole Health (NIWH) have jointly announced a partnership focused ... addressing unsolved, chronic medical case studies. The study will be conducted with NIWH ...
Breaking Medicine News(10 mins):Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 2Health News:Isabel Healthcare and the National Institute of Whole Health Announce Partnership for a Pilot Study Using the Isabel Diagnostic Support Tool and Knowledge Organizer 3
... March 23 Kiley Carlson of Sioux City, IA ... Tuesday, March 31, 2009 to meet with congressional leaders ... and more research toward a cure for epilepsy.Carlson, 16, ... country participating in Kids Speak Up! , a ...
... Money and Improves Health With Advanced but Affordable ... money and save your health in these tough ... part medical detective as well as a skilled ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-b ) , (Photo: ...
... in Germany have offered an endoscopic examination of the ... from the age of 55. Germany was the first ... a part of its statutory early cancer detection program. ... at DKFZ have now published a first calculation of ...
... Percent of 20,000+ Customer Service Centers EvaluatedPHILADELPHIA, March ... Wolters Kluwer Health announced today that its customer ... Excellence" certification from BenchmarkPortal and the Center for ... The company was recognized for outstanding service to ...
... papers, from Aegis Health Group reveals bottom-line value ... March 23 Hospital-employer partnerships are instrumental in ... to reduce health-related costs. A new thought ... Health Management Programs Bring Bottom-Line Benefits," explores the ...
... NoiseBuster Active Noise Reduction Earmuff Delivers Best Hearing ... Noise Reduction ("ANR") Safety Earmuff is specifically designed ... and garden power equipment such as mowers, loaders, ... and other noisy devices. Whether you work in ...
Cached Medicine News:Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Saving Money While Protecting Your Health in Tough Economic Times 2Health News:Saving Money While Protecting Your Health in Tough Economic Times 3Health News:Germany: Colonoscopy prevents 15,000 cancer cases 2Health News:Wolters Kluwer Health Customer Service Organization Awarded 'Center of Excellence' Certification 2Health News:Wolters Kluwer Health Customer Service Organization Awarded 'Center of Excellence' Certification 3Health News:Hospital-Employer Partnerships Create Affinity With Privately Insured Consumers, Lead to Cost Savings and Better Health 2Health News:NoiseBuster(R) Safeguards Hearing by Utilizing Cutting-Edge Technology to Attenuate Power Equipment Noise 2
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
... powder reagent once reconstituted offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
LCD chart display...
Mobile offers full life cycle service for Sp02 accessories that are the vital link between pulse oximeter and patient...
Medicine Products: